PDE5A and pulmonary arterial hypertension: Phosphodiesterase-5 (PDE5) inhibitors, commonly used for erectile dysfunction and pulmonary arterial hypertension, are emerging as potential candidates for repurposing in diabetes management due to their favourable safety profile and potential cardiovascular benefits.